FDA inspection
Beximco Pharmaceuticals Limited: FDA inspection ending Mar 30, 2023
FDA inspection 1201162 · Voluntary Action Indicated (VAI) · Gazipur
Key facts
| Inspection ID | 1201162 |
|---|---|
| Firm | Beximco Pharmaceuticals Limited |
| FEI number | 3008763868 |
| Address | Tongi, 126 Kathaldia |
| City | Gazipur |
| Country | Bangladesh |
| Fiscal year | 2023 |
| Inspection end date | Mar 30, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data